首页> 外文OA文献 >Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab

【2h】

Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab

机译：4-1bb配体和激动剂单克隆抗体utomilimab有限的交联4-1bb

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yan Li; Shuguang Tan; Chang Zhang; Yan Chai; Mengnan He; Catherine W.-H. Zhang; Qihui Wang; Zhou Tong; Kefang Liu; Yifan Lei; William J. Liu; Yingxia Liu; Zhigang Tian; Xuetao Cao; Jinghua Yan; Jianxun Qi; Po Tien; Shan Gao; George F. Gao;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab [J] . Yan Li, Shuguang Tan, Chang Zhang, Cell Reports . 2018,第4期

机译：4-1BB配体与激动剂单克隆抗体Utomilumab限制4-1BB的交联
2. First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20(+) Non-Hodgkin Lymphomas [J] . Gopal Ajay K., Levy Ronald, Houot Roch, Clinical cancer research: an official journal of the American Association for Cancer Research . 2020,第11期

机译：乌莫耳，4-1BB / CD137激动剂的首先人体研究，与卵泡和其他CD20（+）非霍奇金淋巴瘤患者的Rituximab组合
3. Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer [J] . Segal Neil H., He Aiwu R., Doi Toshihiko, Clinical cancer research: an official journal of the American Association for Cancer Research . 2018,第8期

机译：I阶段I代理utomilumab（PF-05082566），4-1bb / cd137激动剂，晚期癌症患者
4. Screening, Optimization and Characterization of a Novel 4-1BB x 5T4 ADAPTIR Bispecific Antibody [C] . David Bienvenue, Laura von Schantz, Lynda Misher, Protein Engineering Summit. . 2018

机译：一种新型4-1BB×5T4适应性双特异性抗体的筛选，优化和表征
5. A novel form of 4-1BB ligand for immunomodulation [D] . Elpek, Kutlu Goksu 2007

机译：一种新型形式的4-1BB配体用于免疫调节
6. IMMU-03. COMBINATION OF RADIOTHERAPY WITH A 4-1BB AGONIST ANTIBODY AND A TIM-3 APTAMER RESULTS IN ENHANCED SURVIVAL IN A DIPG MODEL [O] . Naiara Martinez-Velez, Miguel Marigil, Javier Aristu, 2017

机译：IMMU-03。在DIPG模型中将放射治疗与4-1BB激动剂抗体和TIM-3 Aptamer结果联合用于增强生存率
7. First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20+ Non-Hodgkin Lymphomas [O] . Ajay K. Gopal, Ronald Levy, Roch Houot, 2020

机译：乌马阡尼米尔，4-1BB / CD137激动剂的第一次人类研究与卵泡和其他CD20 +非霍奇金淋巴瘤患者的Rituximab组合
8. Mouse Monoclonal Antibody Specific for an Allotypic Determinant of the Igh(a) Allele of Murine IgM: Genetic and Functional Analysis of Igh-6a Epitopes Using Anti-IgM Monoclonal Antibodies. [R] . Sieckmann, D. G., Stall, A. M., Subbarao, B. 1991

机译：小鼠单克隆抗体特异性针对Igh（a）小鼠Igm等位基因的同种型决定因素：使用抗Igm单克隆抗体的Igh-6a表位的遗传和功能分析。

Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab

著录项

引文网络

相似文献

相关主题

期刊订阅